Clinical Trial Update: Intervention Using Vitamin D for Elevated Urinary Albumin Treated With Losartan in Diabetes (IDEAL) [Phase 2, Phase 3]

View source ↗

Summary

This terminated IDEAL trial evaluated adding Vitamin D to losartan to reduce albuminuria in patients with diabetic nephropathy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Nephropathy

Drugs mentioned

• Losartan (losartan)
• Vitamin D (Cholecalciferol)

Snippet

Sponsor: Weill Cornell Medical College in Qatar | Conditions: Diabetic Nephropathies | Phase 2, Phase 3 | Status: TERMINATED